Wells Fargo’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
ACM
TGA
PBPIA
NCM
AC
RC
Wells Fargo's RLYB Position: Q2 2026 in Review
Wells Fargo held its Rallybio (RLYB) position steady in Q2 2026 at 37 shares worth $592. The position accounts for ﹤0.01% of the portfolio, ranked #6505.
Wells Fargo first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $67.2K in Q2 2023. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.
- Wells Fargo held 37 shares of Rallybio worth $592 as of Q2 2026.
- Wells Fargo left its Rallybio share count unchanged in Q2 2026.
- Rallybio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6505 holding.
- Wells Fargo first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
- Wells Fargo's Rallybio position peaked at $67.2K in Q2 2023.
- 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.